1. Home
  2. BNTX vs LII Comparison

BNTX vs LII Comparison

Compare BNTX & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.35

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$480.02

Market Cap

17.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
LII
Founded
2008
1895
Country
Germany
United States
Employees
N/A
12900
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
17.2B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
BNTX
LII
Price
$91.35
$480.02
Analyst Decision
Strong Buy
Hold
Analyst Count
13
13
Target Price
$133.46
$566.58
AVG Volume (30 Days)
748.2K
420.5K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
1.00%
EPS Growth
N/A
1.11
EPS
N/A
3.35
Revenue
N/A
$5,195,300,000.00
Revenue This Year
N/A
$6.85
Revenue Next Year
$3.37
$5.76
P/E Ratio
N/A
$147.01
Revenue Growth
N/A
N/A
52 Week Low
$79.81
$434.06
52 Week High
$124.00
$689.44

Technical Indicators

Market Signals
Indicator
BNTX
LII
Relative Strength Index (RSI) 42.37 41.14
Support Level $90.67 $479.34
Resistance Level $112.44 $568.31
Average True Range (ATR) 3.00 15.12
MACD -0.70 -4.95
Stochastic Oscillator 29.57 6.52

Price Performance

Historical Comparison
BNTX
LII

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About LII Lennox International Inc.

Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounts for 67% of sales and commercial HVAC (building climate solutions) accounts for the remaining 33% of sales. Lennox's commercial exposure is what its peers refer to as residential and light commercial, and lacks the scale and complexity of what is referred to as an applied solution. The company goes to market with multiple brands, but Lennox is its flagship HVAC brand.

Share on Social Networks: